We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+4.55%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
10 Year Est. Return
AUM
$12.9B
AUM Growth
+$12.9B
Cap. Flow
+$2.44B
Cap. Flow %
18.95%
Top 10 Hldgs %
13.49%
Holding
489
New
192
Increased
92
Reduced
78
Closed
35

Top Sells

Rank Stock Value
1
HQY icon
HealthEquity
HQY
+$34.8M
2
RCL icon
Royal Caribbean
RCL
+$33.2M
3
OMCL icon
Omnicell
OMCL
+$29.2M
4
TYL icon
Tyler Technologies
TYL
+$29.1M
5
CGNX icon
Cognex
CGNX
+$28.3M

Sector Composition

Rank Sector Weight
1 Healthcare 18.54%
2 Technology 17.46%
3 Industrials 16.92%
4 Consumer Discretionary 15.93%
5 Financials 10.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CI icon
176
Cigna
CI
$78.4B
$25.5M 0.2%
154,619
+15,325
+11% +$2.98M
ANDV
177
DELISTED
Andeavor
ANDV
$25.4M 0.2%
+252,200
New +$26.3M
FBIN icon
178
Fortune Brands Innovations
FBIN
$5.86B
$25.3M 0.2%
517,929
+80,407
+18% +$4.48M
FND icon
179
Floor & Decor
FND
$6.03B
$25.2M 0.2%
488,529
PNC icon
180
PNC Financial Services
PNC
$99.1B
$25.2M 0.2%
169,707
-6,734
-4% -$1.05M
AMD icon
181
Advanced Micro Devices
AMD
$700B
$24.9M 0.19%
2,616,141
BLUE
182
DELISTED
bluebird bio
BLUE
$24.7M 0.19%
11,796
PLAY icon
183
Dave & Buster's
PLAY
$357M
$24.7M 0.19%
615,426
EVRI
184
DELISTED
Everi Holdings
EVRI
$24.6M 0.19%
3,839,352
+561,453
+17% +$4.18M
ZAYO
185
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$24.4M 0.19%
701,006
+71,557
+11% +$2.58M
APTV icon
186
Aptiv
APTV
$12.3B
$24.3M 0.19%
298,286
+258,341
+647% +$23.4M
BCO icon
187
Brink's
BCO
$5.01B
$24.3M 0.19%
345,004
SLAB icon
188
Silicon Laboratories
SLAB
$7.14B
$24.2M 0.19%
+278,536
New +$26.3M
INWK
189
DELISTED
InnerWorkings, Inc.
INWK
$24M 0.19%
+264,983
New +$2.51M
ALLE icon
190
Allegion
ALLE
$13.5B
$23.7M 0.18%
284,995
+36,937
+15% +$3.1M
UMPQ
191
DELISTED
Umpqua Holdings Corp
UMPQ
$23.4M 0.18%
+1,094,600
New +$23.9M
WST icon
192
West Pharmaceutical
WST
$23.7B
$23.2M 0.18%
272,479
-123,143
-31% -$11.5M
CTLT
193
DELISTED
CATALENT, INC.
CTLT
$22.9M 0.18%
584,355
-86,527
-13% -$3.68M
CUZ icon
194
Cousins Properties
CUZ
$5.31B
$22.8M 0.18%
+657,504
New +$23M
DAL icon
195
Delta Air Lines
DAL
$56.7B
$22.7M 0.18%
437,124
+42,597
+11% +$2.35M
IQV icon
196
IQVIA
IQV
$40.7B
$22.6M 0.18%
+236,395
New +$23.9M
AAPL icon
197
Apple
AAPL
$4.97T
$22.6M 0.18%
542,648
-21,528
-4% -$927K
LMT icon
198
Lockheed Martin
LMT
$131B
$22.1M 0.17%
66,371
-2,633
-4% -$896K
STLD icon
199
Steel Dynamics
STLD
$36.2B
$21.9M 0.17%
+495,825
New +$22.8M
BMRN icon
200
BioMarin Pharmaceuticals
BMRN
$11.9B
$21.6M 0.17%
279,498
+22,779
+9% +$1.95M

Similar funds

Carillon Tower Advisers's Q1 2018 Portfolio in Review

As of Q1 2018, Carillon Tower Advisers held 489 positions worth $12.9B, up 136,756% from $9.4M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Carillon Tower Advisers deployed $2.44B of net new capital in Q1 2018, opening 192 new positions and adding to 92 existing holdings. Its largest new stake was Voya Financial: 871,250 shares worth $4.4M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was HealthEquity, an estimated $34.8M trimmed.

  • Carillon Tower Advisers's largest Q1 2018 buy was Voya Financial: 871,250 shares worth $4.4M.
  • Carillon Tower Advisers added most to DXC Technology in Q1 2018, an estimated $101M increase.
  • Carillon Tower Advisers's biggest Q1 2018 reduction was HealthEquity, cutting an estimated $34.8M.
  • Carillon Tower Advisers fully exited Prestige Consumer Healthcare in Q1 2018, selling an estimated $404K.
  • Carillon Tower Advisers's ten largest holdings make up 13% of its $12.9B portfolio in Q1 2018.
  • Carillon Tower Advisers opened 192 new positions and closed 35 in Q1 2018.
  • Carillon Tower Advisers's portfolio value rose 136,756% quarter-over-quarter to $12.9B.

Based on Carillon Tower Advisers's 13F filing for Q1 2018, filed 14 May 2018.